| Timothy E Lindley, MD | |
|
111 17th Ave E Ste 101, Alexandria, MN 56308-5274 | |
| (320) 762-1511 | |
| (320) 762-1935 |
| Full Name | Timothy E Lindley |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 19 Years |
| Location | 111 17th Ave E Ste 101, Alexandria, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659589240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 56088 (Minnesota) | Primary |
| 207T00000X | Neurological Surgery | 12131 (North Dakota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alomere Health | Alexandria, MN | Hospital |
| Glacial Ridge Hospital | Glenwood, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas County Hospital | 0648171413 | 101 |
News Archive
STI Medical Systems, an industry leader in medical imaging systems and machine vision software, announced today that the U.S. Food and Drug Administration has given clearance to the Company's precedent-setting ImageSense technology for use in colposcopy.
Alere Inc., a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced the availability in Europe of the Alere i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes. The test is now commercially available in Austria, France, Spain, Switzerland, Germany, Italy and the UK.
People with epilepsy have a rare risk of sudden death. A new study shows that risk may apply even to people whose epilepsy is well-controlled, which is contrary to previous, smaller studies that showed the risk was highest among those with severe, difficult-to-treat epilepsy.
Cochlear implants electronic devices inserted surgically in the ear to allow deaf people to hear may restore normal auditory pathways in the brain even after many years of deafness.
› Verified 9 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
STI Medical Systems, an industry leader in medical imaging systems and machine vision software, announced today that the U.S. Food and Drug Administration has given clearance to the Company's precedent-setting ImageSense technology for use in colposcopy.
Alere Inc., a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced the availability in Europe of the Alere i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes. The test is now commercially available in Austria, France, Spain, Switzerland, Germany, Italy and the UK.
People with epilepsy have a rare risk of sudden death. A new study shows that risk may apply even to people whose epilepsy is well-controlled, which is contrary to previous, smaller studies that showed the risk was highest among those with severe, difficult-to-treat epilepsy.
Cochlear implants electronic devices inserted surgically in the ear to allow deaf people to hear may restore normal auditory pathways in the brain even after many years of deafness.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy E Lindley, MD 111 17th Ave E Ste 101, Alexandria, MN 56308-5274 Ph: (320) 762-1511 | Timothy E Lindley, MD 111 17th Ave E Ste 101, Alexandria, MN 56308-5274 Ph: (320) 762-1511 |
News Archive
STI Medical Systems, an industry leader in medical imaging systems and machine vision software, announced today that the U.S. Food and Drug Administration has given clearance to the Company's precedent-setting ImageSense technology for use in colposcopy.
Alere Inc., a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced the availability in Europe of the Alere i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes. The test is now commercially available in Austria, France, Spain, Switzerland, Germany, Italy and the UK.
People with epilepsy have a rare risk of sudden death. A new study shows that risk may apply even to people whose epilepsy is well-controlled, which is contrary to previous, smaller studies that showed the risk was highest among those with severe, difficult-to-treat epilepsy.
Cochlear implants electronic devices inserted surgically in the ear to allow deaf people to hear may restore normal auditory pathways in the brain even after many years of deafness.
› Verified 9 days ago